Deep Vein Thrombosis Deep Vein Thrombosis DVT facts, statistics, and therapeutic options MICHAEL A...
of 34/34
Deep Vein Deep Vein Thrombosis Thrombosis DVT facts, statistics, DVT facts, statistics, and therapeutic options and therapeutic options MICHAEL A ARATA MD MICHAEL A ARATA MD INTERVENTIONAL RADIOLOGY INTERVENTIONAL RADIOLOGY MEMORIAL UNIVERSITY MEDICAL CENTER MEMORIAL UNIVERSITY MEDICAL CENTER SAVANNAH, GEORGIA SAVANNAH, GEORGIA
Deep Vein Thrombosis Deep Vein Thrombosis DVT facts, statistics, and therapeutic options MICHAEL A ARATA MD INTERVENTIONAL RADIOLOGY INTERVENTIONAL RADIOLOGY
Text of Deep Vein Thrombosis Deep Vein Thrombosis DVT facts, statistics, and therapeutic options MICHAEL A...
Slide 1
Deep Vein Thrombosis Deep Vein Thrombosis DVT facts,
statistics, and therapeutic options MICHAEL A ARATA MD
INTERVENTIONAL RADIOLOGY INTERVENTIONAL RADIOLOGY MEMORIAL
UNIVERSITY MEDICAL CENTER SAVANNAH, GEORGIA SAVANNAH, GEORGIA DVT
facts, statistics, and therapeutic options MICHAEL A ARATA MD
INTERVENTIONAL RADIOLOGY INTERVENTIONAL RADIOLOGY MEMORIAL
UNIVERSITY MEDICAL CENTER SAVANNAH, GEORGIA SAVANNAH, GEORGIA
The Problem of DVT: Statistics DVT occurs in approx. 2 million
Americans each year. Approx 1/3 develop PEDVT occurs in approx. 2
million Americans each year. Approx 1/3 develop PE The combined
annual incidence for DVT is approximately 2.5%-5% of the adult
populationThe combined annual incidence for DVT is approximately
2.5%-5% of the adult population DVT recurs in 5-10% of patients the
year after anticoagulationDVT recurs in 5-10% of patients the year
after anticoagulation DVT recurs in 30% of patients eight years
after anticoagulationDVT recurs in 30% of patients eight years
after anticoagulation 1996 American Heart Association Scientific
Statement on DVT
Slide 4
Risk Factors for DVT Age >40 years Cancer Obesity Previous
or family history of DVT/PE Recent surgery Paralysis or immobility
Contraceptives/Hormone replacement therapy Pregnancy Serious
illness: CHF, MI, sepsis Coagulation disorders 4
Slide 5
DVT: Clinical Presentation Calf pain/tenderness Swelling Calor,
rubor Cyanosis or pallor Superficial venous dilatation Loss of
pulses in severe DVT 5
Causes of Limb Swelling: Chronic Post-phlebitic syndrome
Chronic venous insufficiency Venous obstruction Other Heart failure
RSD Hypoproteinemia- cirrhosis Medication 7
Slide 8
DVT Treatment Strategies: Timing Sooner is Better! < 3 Weeks
Good < 1 Week Better < 3 Days Best 8
Slide 9
Rationale for Early Treatment of DVT Early treatment increases
probability of maintaining normal valve function Damaged valves
lead to venous insufficiency Decrease recurrent DVT risk Restore
normal venous flow Clear thrombogenic substrate Decrease risk for
PE Asymptomatic PE occurs in majority of patients with DVT 9
Slide 10
Delayed Complications: Post-Phlebitic Syndrome Post-Phlebitic
Syndrome -- spectrum symptoms seen after DVT pain edema
pigmentation ulcer Occurs in 50 to 70% cases proximal DVT
Prevalence estimated to be as high as 2 percent in the general
population 10
DVT Treatment Strategies: Historical Standard Primary
intention-Prevent PE Anticoagulation Heparin, Warfarin, LMWH IVC
Filter Placement Catheter-Directed Thrombolytics Select cases
12
Slide 13
Vascular Thrombosis Technology has revolutionized field
Lysis/thrombectomy STD of care MI Acute stroke Acute limb ischemia
Massive PE DVT- effort thrombosis/SVC syndrome
Slide 14
Why Not LE DVT? Large clot burden Systemic lysis-not effective
Initial revascularization devices inadequate Catheter directed
lysis more effective Costly-ICU stay Poor Patient tolerance
Slide 15
Treatment Strategies: Investigational New treatments to rapidly
remove thrombus: Mechanical Thrombectomy Physical removal of clot
burden Often used in combination with lytics Power Pulse Spray
Accelerated thrombolysis delivered by AngioJet system 15
Slide 16
Clinical Experience: Mechanical Thrombectomy for DVT Experience
as reported by K. Kasirajan, MD 17 patients with extensive DVT
treated with AngioJet 7 of 17 patients had
Clinical Experience: Mechanical Thrombectomy for DVT Complete
(> 90% of initial thrombus removed) Substantial (> 50% -- 90%
of initial thrombus removed) Partial (> 50% of initial thrombus
removed) No Response Response to AngioJet Treatment 18 Kasirajan K,
Arata M, Swischuk S, Hunter D, Cazenave C, Rheolytic thrombectomy
for management of venous thrombosis: Results of a multicenter
venous registry. J Vasc Interven Radiol 2003: 14: S16 9% 16% 25%
50%
Slide 19
Clinical Experience: Mechanical Thrombectomy for DVT Reported
Conclusions: AngioJet Mechanical thrombectomy is a safe adjunct or
alternative to thrombolysis for DVT Debulking with AngioJet may
result in elimination or reduction of lytic dose A sufficiently
powered study is warranted to assess effects 19 Kasirajan K, Arata
M, Swischuk S, Hunter D, Cazenave C, Rheolytic thrombectomy for
management of venous thrombosis: Results of a multicenter venous
registry. J Vasc Interven Radiol 2003: 14: S16
Slide 20
AngioJet Xpeedior 120 20
Slide 21
Clinical Experience: Power Pulse Spray Reported Conclusions: 25
lower extremities Thrombolytic success 100% Same day treatment 52%
Procedure complete after Power Pulse Spray 80% 21 Arata M, Pappas
J, Personal experience
Slide 22
Deep Vein Thrombosis Deep Vein Thrombosis Mechanical
Thrombectomy Case Examples This program was developed for
educational purposes only. The AngioJet System is not indicated for
use in the venous system.
Sequential Venograms Following AngioJet Thrombectomy Sequential
venograms performed following thrombectomy passes
Slide 25
Completion Venogram Completion LE venogram Completion pelvic
venogram Completion cavogram
Slide 26
Deep Vein Thrombosis Deep Vein Thrombosis Power Pulse Spray
Case Examples This program was developed for educational purposes
only. The AngioJet System is not indicated for use in the venous
system.
Following Power Pulse Spray Completion popliteal venogram
Completion femoral venogram Completion pelvic venogram
Slide 33
Summary DVT Major healthcare problem Management focus- decades
old Prevent propagation Anticoagulation IVC filter Revolution in
vascular technology
Slide 34
Summary Power Pulse Spray Same day treatment-cost effective
Preliminary results superior to lysis Potentially safer
Substantially more patient friendly